Insights into the Tuberculosis Research Portfolio ​ of the Instituto Nacional de Saúde, Mozambique

Media 10 Sep 2024
121

Celso Khosa, MD, PhD​
Researcher at the Instituto Nacional de Saúde, Mozambique​

Speaker: Dr. Khosa is the Director of PolanaCaniço Health Research and Training Center (CISPOC), Instituto Nacional de Saúde (INS), Maputo, Mozambique. He did his medical training at Eduardo Mondlane University, Maputo, Mozambique and obtained his PhD in Medical Research/International Health at the University of Munich, Germany. He was a member of the Institutional Bioethics Committee. Dr. Khosa is currently the Country Principal Investigator and Chief Investigator in several TB studies, including clinical trials for new drugs in TB and HIV treatment in pediatric and adult populations. His main research interest includes Tuberculosis, Digital health, COVID-19, HIV and associated comorbidities. Dr. Khosa and LSTM’s Dr. Tom Wingfield are joint recipients of a Dorothy Temple Cross International Tuberculosis Collaboration award and a supplementary Meade International Travel Award in Epidemiology, from the Medical Research Foundation. Dr Khosa is visiting LSTM from now until November 2024.

Topic: The goal of this presentation is to provide a clear understanding of Mozambique’s TB landscape, the foundational elements of our research program, and the strategic direction of our current and future research efforts. This will include insights from completed studies that have shaped our current strategies, as well as the latest research efforts aimed at addressing emerging challenges in TB control and treatment.